8-K
Current Report
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-25-088482
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading fdmt-20250617.htm…